Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

TLR pathways and IFN‐regulatory factors: To each its own

TLR pathways and IFN‐regulatory factors: To each its own TLR trigger the induction of type I IFN (IFN‐alpha/beta), providing a crucial mechanism of anti‐viral defense. Until recently, TLR were thought to induce type I IFN responses by activating two transcription factors which belong to the IFN‐regulatory factor (IRF) family, IRF‐3 and IRF‐7. TLR‐3 and TLR‐4 induce IFN‐beta by activating IRF‐3; TLR‐9 induces IFN‐alpha and IFN‐beta through IRF‐7, at least when engaged by type A CpG oligonucleotides (CpG‐A) in plasmacytoid DC (pDC). In this issue of the European Journal of Immunology, it is demonstrated that TLR‐9 induces IFN‐beta when engaged by type B CpG oligonucleotides (CpG‐B) in myeloid DC and macrophages. Remarkably, this response is independent of IRF‐3/7 and, in fact, requires another IRF family member, IRF‐1. IRF‐1 is recruited by TLR‐9 through the adaptor MyD88. Deficiency of the TLR‐9→IRF‐1→IFN‐beta pathway results in impaired anti‐viral responses not only in vitro but also in vivo. These results demonstrate that TLR induce IFN‐alpha or IFN‐beta responses by activating distinct IRF, depending on the TLR ligand and the cell type. These distinct TLR‐IRF pathways may allow the immune system to tailor its responses to viral pathogens. See accompanying article http://dx.doi.org/10.1002/eji.200636767 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Immunology Wiley

TLR pathways and IFN‐regulatory factors: To each its own

European Journal of Immunology , Volume 37 (2) – Feb 1, 2007

Loading next page...
 
/lp/wiley/tlr-pathways-and-ifn-regulatory-factors-to-each-its-own-1wJFu7dJqg

References (11)

Publisher
Wiley
Copyright
Copyright © 2007 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
ISSN
0014-2980
eISSN
1521-4141
DOI
10.1002/eji.200637009
pmid
17273997
Publisher site
See Article on Publisher Site

Abstract

TLR trigger the induction of type I IFN (IFN‐alpha/beta), providing a crucial mechanism of anti‐viral defense. Until recently, TLR were thought to induce type I IFN responses by activating two transcription factors which belong to the IFN‐regulatory factor (IRF) family, IRF‐3 and IRF‐7. TLR‐3 and TLR‐4 induce IFN‐beta by activating IRF‐3; TLR‐9 induces IFN‐alpha and IFN‐beta through IRF‐7, at least when engaged by type A CpG oligonucleotides (CpG‐A) in plasmacytoid DC (pDC). In this issue of the European Journal of Immunology, it is demonstrated that TLR‐9 induces IFN‐beta when engaged by type B CpG oligonucleotides (CpG‐B) in myeloid DC and macrophages. Remarkably, this response is independent of IRF‐3/7 and, in fact, requires another IRF family member, IRF‐1. IRF‐1 is recruited by TLR‐9 through the adaptor MyD88. Deficiency of the TLR‐9→IRF‐1→IFN‐beta pathway results in impaired anti‐viral responses not only in vitro but also in vivo. These results demonstrate that TLR induce IFN‐alpha or IFN‐beta responses by activating distinct IRF, depending on the TLR ligand and the cell type. These distinct TLR‐IRF pathways may allow the immune system to tailor its responses to viral pathogens. See accompanying article http://dx.doi.org/10.1002/eji.200636767

Journal

European Journal of ImmunologyWiley

Published: Feb 1, 2007

There are no references for this article.